Coronary heart disease Integrative medicine Syndrome differe

  本文关键词：崔尚志中西医结合生平及思想，由笔耕文化传播整理发布。

崔尚志中西医结合生平及思想

Introduction to Cui Shang-Zhi＇s Clinical Biography and Integrative Medical Thought

[1] [2]

Zhang Huiyong , Yang Guanlin （1 Blood and Vessel Research Laboratory, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110032, China; 2 Di

[1]辽宁中医药大学附属医院血脉病研究室,沈阳110032; [2]辽宁中医药大学中西医结合临床学科,沈阳110847

文章摘要：崔尚志（1924—1989）,辽宁名医,中西医结合的开拓者,活血化瘀研究的先驱者,毕生从事中西医结合防治冠心病的临床与研究。他参与研制了＂冠心1号＂等制剂,通过临床系列研究,总结其疗效规律,并率先开展动物实验研究,探讨中药制剂防治冠心病的作用机制。他主张中医＂辨病＂＂辨证＂与西医＂辨病＂相结合的方法辨证论治,以《内经》理论指导冠心病治疗,将冠心病辨为＂心痹＂病,分别气滞血瘀、气虚血瘀两大主证,并根据冠心病临床合并症不同,再分为阴虚阳亢等八个兼证。

Abstr：Cui Shangzhi（ 1924—1989） was a very famous integrative physician in China. As an integrative pioneer,he started the research on the treatment of blood activating and stasis removing. He devoted all his life to the integrative medicine. Dr. Cui specialized in treating coronary heart disease（ CHD） combining Chinese herbs with western medicine. He invented a Chinese herb formula called guanxin 1 with his colleagues,and did a series of clinical and basic researches on it,through which he proved the effect of guanxin 1 on treating CHD and expounded its therapeutic mechanism. Dr. Cui advocated that the syndrome differentiation should combine Chinese medical disease differentiation with syndrome differentiation according to western medical diseases. In Nei Jing,CHD is considered as Xin Bi,and Dr. Cui differentiated the syndromes of Xin Bi into two main syndromes and eight subordinate syndromes according to CHD and its morbidity.

文章关键词：

Keyword：:Coronary heart disease Integrative medicine Syndrome differentiation Disease differentiation Blood activating and stasis removing

课题项目：国家中医药管理局国家中医临床研究基地建设项目（编号：国中医药发[2008]23号）; 国家中医药管理局“十一五”中医药重点学科中西医结合临床学科建设项目（编号：国中医药发[2009]30号）

  本文关键词：崔尚志中西医结合生平及思想，由笔耕文化传播整理发布。